May 2, 2018

Athersys and Healios Alter Deadline to Expand their MultiStem Partnership

Cleveland biotechnology company Athersys and Healios, its partner in Japan, are giving themselves more time to complete an expansion of the development and commercialization collaboration involving Athersys’ MultiStem cell therapy treatment.

Read More  >